The 3,600 sqft facility will help develop the MIMIX sustained-release intradermal microneedle patch, which is planned for proof-of-concept trials for COVID-19 in 2022
The agenda and networking opportunities make the Cleanroom Technology Conference a can't-miss event, you'll have the chance to connect with key stakeholders, suppliers, and...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.